ImipenemCilastatinQualityChecker
Imipenem Cilastatin
Imipenem Cilastatin Quality Checker — Carbapenem Antibiotic (Ph. Eur., USP) ℹ️ The utility checks content of both APIs, imipenem polymers, pH, sterility, endotoxins. ℹ️ Does not use machine learning — rule-based logic only. ⚠️ CRITICAL! Imipenem Polymers ≤2.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg! Usage: ImipenemCilastatinQualityChecker.exe → demo mode ImipenemCilastatinQualityChecker.exe input.csv output.json → evaluate data Input format: BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected Example: IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0 — WHY IS THIS NEEDED? Imipenem + Cilastatin combination — broad-spectrum carbapenem antibiotic: • Imipenem: Contains a β-lactam ring prone to polymerization. High polymer levels significantly increase the risk of anaphylactic reactions. Limit is strict (≤2.0%). • Cilastatin: Dihydropeptidase I inhibitor protecting imipenem from renal degradation. Control of its impurities is important for maintaining combination efficacy. • Aqueous solution pH: Critical for imipenem stability. Range 6.0–8.0 prevents β-lactam ring hydrolysis. • Parenteral form: Supplied as lyophilizate. Requirements for sterility, pyrogenicity (≤1.0 EU/mg), and absence of particulates (USP <788>) are absolute. ⚠️ CRITICAL: • Content of both APIs: 95–105% • Imipenem Polymers: ≤ 2.0% • Imipenem Deamidated/Hydrolyzed Impurity: ≤ 1.0% • Total Impurities: ≤ 4.0% • pH: 6.0–8.0 • Sterility: No growth • Bacterial Endotoxins: ≤ 1.0 EU/mg • Particles >25 µm: ≤ 60 counts/mL • Appearance: White or almost white powder / clear solution • Pre-sterilization Microbiology: TAMC ≤100 CFU/g, TYMC ≤10 CFU/g ⚠️ Note: Utility places special emphasis on parenteral β-lactam antibiotic safety. Any sterility breach or polymer limit exceedance leads to immediate batch rejection. pH control is important for ensuring imipenem molecule stability during storage and reconstitution.
input.csv
BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Imipenem Cilastatin Quality Checker utility is used for Imipenem Cilastatin. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API expansion
Tags: antibiotics, antivirals, API, biologics, endotoxins, essential medicines, global market, impurities, microbiology, oncology, sterility
2. Execution modes
ImipenemCilastatinQualityChecker.exe → demo mode ImipenemCilastatinQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- purity and impurities
- microbiology and pathogens
- heavy metals / elemental impurities
- pH and physicochemical parameters
4. Domain limits and critical parameters
- ⚠️ CRITICAL! Imipenem Polymers ≤2.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg!
- Imipenem: Contains a β-lactam ring prone to polymerization. High polymer levels significantly increase the risk of anaphylactic reactions. Limit is strict (≤2.0%).
- Parenteral form: Supplied as lyophilizate. Requirements for sterility, pyrogenicity (≤1.0 EU/mg), and absence of particulates (USP <788>) are absolute.
- ⚠️ CRITICAL:
- Content of both APIs: 95–105%
- Imipenem Polymers: ≤ 2.0%
- Imipenem Deamidated/Hydrolyzed Impurity: ≤ 1.0%
- Total Impurities: ≤ 4.0%
- pH: 6.0–8.0
- Sterility: No growth
- Bacterial Endotoxins: ≤ 1.0 EU/mg
- Particles >25 µm: ≤ 60 counts/mL
- Appearance: White or almost white powder / clear solution
- Pre-sterilization Microbiology: TAMC ≤100 CFU/g, TYMC ≤10 CFU/g
- ⚠️ Note: Utility places special emphasis on parenteral β-lactam antibiotic safety. Any sterility breach or polymer limit exceedance leads to immediate batch rejection. pH control is important for ensuring imipenem molecule stability during storage and reconstitution.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Imipenem Cilastatin with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, purity and impurities, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | IM-CIL-LYO-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Imipenem_Content_Percent | decimal | % | Imipenem Content % | 99.0 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Cilastatin_Content_Percent | decimal | % | Cilastatin Content % | 99.5 | numeric value; compared with assay/purity limit from specification or method |
| 4 | Imipenem_Polymer_Percent | decimal | % | Imipenem Polymer % | 0.8 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | Imipenem_Degradation_Product_Percent | decimal | % | Imipenem Degradation Product % | 0.4 | numeric value; compared with individual or total impurity limit |
| 6 | Imipenem_Total_Impurities_Percent | decimal | % | Imipenem Total Impurities % | 1.5 | mandatory numeric value; rule comparison is performed by the utility |
| 7 | Cilastatin_Oxidized_Impurity_Percent | decimal | % | Cilastatin Oxidized Impurity % | 0.2 | numeric value; compared with individual or total impurity limit |
| 8 | Cilastatin_Isomer_Percent | decimal | % | Cilastatin Isomer % | 0.1 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | Cilastatin_Total_Impurities_Percent | decimal | % | Cilastatin Total Impurities % | 0.4 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | Total_All_Impurities_Percent | decimal | % | Total All Impurities % | 2.0 | mandatory numeric value; rule comparison is performed by the utility |
| 11 | pH_Value | decimal | pH | p H Value | 7.0 | mandatory numeric value; rule comparison is performed by the utility |
| 12 | Loss_On_Drying_Percent | decimal | % | Loss On Drying % | 0.3 | mandatory numeric value; rule comparison is performed by the utility |
| 13 | Heavy_Metals_ppm | decimal | ppm | Heavy Metals ppm | 5 | numeric value; checked as elemental/metal impurity |
| 14 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 15 | Endotoxin_EU_per_mg | decimal | EU/ml | Endotoxin EU per mg | 0.15 | numeric value; critical safety attribute compared with endotoxin limit |
| 16 | Particulates_10_25um | decimal | as specified | Particulates 10 25um | 100 | mandatory numeric value; rule comparison is performed by the utility |
| 17 | Particulates_gt_25um | decimal | as specified | Particulates gt 25um | 5 | mandatory numeric value; rule comparison is performed by the utility |
| 18 | Appearance_Score | decimal | as specified | Appearance Score | 0 | mandatory numeric value; rule comparison is performed by the utility |
| 19 | TAMC | decimal | as specified | TAMC | 10 | numeric value; compared with microbiological limits |
| 20 | TYMC | decimal | as specified | TYMC | 2 | numeric value; compared with microbiological limits |
| 21 | EColi_Detected | boolean / flag | 0/1 | EColi Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 22 | Salmonella_Detected | boolean / flag | 0/1 | Salmonella Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
CSV example
BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable ImipenemCilastatinQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Imipenem Cilastatin, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "ImipenemCilastatinQualityChecker",
"api": "Imipenem Cilastatin",
"batchNumber": "IM-CIL-LYO-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "IM-CIL-LYO-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Imipenem_Content_Percent",
"value": "99.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Cilastatin_Content_Percent",
"value": "99.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Imipenem_Polymer_Percent",
"value": "0.8",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Imipenem_Degradation_Product_Percent",
"value": "0.4",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Imipenem_Total_Impurities_Percent",
"value": "1.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Cilastatin_Oxidized_Impurity_Percent",
"value": "0.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Cilastatin_Isomer_Percent",
"value": "0.1",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenInfectious Diseases QC Suite
QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open